МедФарм

@medpharm · health · Russian · active

Subscribers 12.1K Subscribers, last 30 days: 12.1K → 12.1K +0 24h
Reach per post (ERR) 4.4%535 avg views
Posting 13.9/day last 57 minutes ago
Reactions per 1K views 0.4 ❤ 👍 😱

Минздрав РФ выдал компании «Биокад» разрешение на регистрацию первого отечественного окрелизумаба. Препарат будут выпускать в Москве и Санкт-Петербурге. МедФарм в Макс

Views over time

020040060015 Oct 14:5613 Nov 00:1958215 Oct 14:56: 0 views13 Nov 00:19: 582 views
Snapshots we took after posting.
WhenViews
15 Oct 2026, 14:560
13 Nov 2026, 00:19582

Who shared this post

Posts in other channels we index that link to this one. (Forwards with a hidden source can't be traced.)

Nobody yet.